Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in Anticancer Res

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    August 2017
  1. WANG S, DU P, Tang X, An C, et al
    Comparison of Efficiency of Video Endoscopy and Open Inguinal Lymph Node Dissection.
    Anticancer Res. 2017;37:4623-4628.
    PubMed     Text format     Abstract available

    February 2017
  2. SALMINEN E, Niiniviita H, Jarvinen H, Heinavaara S, et al
    Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.
    Anticancer Res. 2017;37:831-834.
    PubMed     Text format     Abstract available

    September 2016
  3. RADES D, Dziggel L, Veninga T, Bajrovic A, et al
    Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer.
    Anticancer Res. 2016;36:4817-9.
    PubMed     Text format     Abstract available

    August 2016
  4. THEODORAKI MN, Lorenz KJ, Schneider J, Thierauf JC, et al
    Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:3973-82.
    PubMed     Text format     Abstract available

    July 2016
  5. ILLUMINATI G, Calio FG, Angelici AM, Pizzardi G, et al
    Outcome of Resection and Chemotherapy versus Chemotherapy Alone for Retroperitoneal Recurrence of Testicular Cancer Involving the Inferior Vena Cava: A Retrospective Cohort Study of 22 Consecutive Patients.
    Anticancer Res. 2016;36:3483-8.
    PubMed     Text format     Abstract available

    April 2016
  6. BOLM L, Janssen S, Bartscht T, Rades D, et al
    Radiotherapy Alone for Malignant Spinal Cord Compression in Young Men with Seminoma.
    Anticancer Res. 2016;36:2033-4.
    PubMed     Text format     Abstract available

    January 2016
  7. MAKINO T, Konaka H, Namiki M
    Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.
    Anticancer Res. 2016;36:313-7.
    PubMed     Text format     Abstract available

    December 2015
  8. SHIOTA M, Takeuchi A, Sugimoto M, Kashiwagi E, et al
    Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer.
    Anticancer Res. 2015;35:6925-32.
    PubMed     Text format     Abstract available

  9. BOUSSIOS S, Attygalle A, Hazell S, Moschetta M, et al
    Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.
    Anticancer Res. 2015;35:6713-22.
    PubMed     Text format     Abstract available

    November 2015
  10. SHIOTA M, Takeuchi A, Sugimoto M, Dejima T, et al
    Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.
    Anticancer Res. 2015;35:6137-45.
    PubMed     Text format     Abstract available

  11. GALLO K, Brickman A, Warren WH, Gattuso P, et al
    Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
    Anticancer Res. 2015;35:6325-7.
    PubMed     Text format     Abstract available

  12. FAUSKE L, Bondevik H, Bruland OS, Ozakinci G, et al
    Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study.
    Anticancer Res. 2015;35:6081-90.
    PubMed     Text format     Abstract available

    October 2015

  13. Diagnosis and Management of Testicular Cancer. The European Point of View.
    Anticancer Res. 2015;35:5709.
    PubMed     Text format    

    July 2015
  14. WINCHESTER D, Ricks-Santi L, Mason T, Abbas M, et al
    SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
    Anticancer Res. 2015;35:3811-9.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.